The Latest in Lung Cancer

Oncology Practice

Partial pleurectomy improved quality of life but not survival in mesothelioma

November 21, 2013

Lung Cancer

Oncology Practice

HPV prevalent in Hispanic nonsmokers with EGFR-positive lung cancer

November 13, 2013

Lung Cancer

Oncology Practice

Inspiratory muscle training improved subjective breathlessness in lung cancer

November 13, 2013

Oncology Practice

Cetuximab adds no benefit in stage III unresectable lung cancer

November 11, 2013

Lung Cancer

Oncology Practice

One-third of cancer patients over age 70 went untreated, Swedish study finds

November 6, 2013

Lung Cancer

Oncology Practice

Real-world snapshot of lung nodule management raises concerns

November 6, 2013

Lung Cancer

Oncology Practice

Onartuzumab plus erlotinib extended overall survival in MET-positive lung cancer

November 5, 2013

Lung Cancer

Oncology Practice

Stereotactic lung radiotherapy of central lung tumors can achieve good overall survival with limited toxicity

November 1, 2013

Lung Cancer

Oncology Practice

Osteopontin level in early non-small cell lung cancer predicts recurrence

October 31, 2013

Lung Cancer

Oncology Practice

Molecular profiling leads to improved targeted treatment

October 29, 2013

Oncology Practice

Tivantinib plus erlotinib may benefit high MET expression non–small cell lung cancers

October 25, 2013

Lung Cancer

Oncology Practice

Nintedanib improves survival in previously treated NSCLC

October 22, 2013

Lung Cancer

Oncology Practice

Immunotherapy induces ‘striking’ responses in non–small cell lung cancer

October 9, 2013

Lung Cancer

Oncology Practice

Alectinib active in ALK-positive, crizotinib-refractory NSCLC

October 9, 2013

Lung Cancer

Oncology Practice

Adaptive radiation therapy aids control of unresectable NSCLC

October 8, 2013

Lung Cancer